scholarly journals Is COVID-19 Fatality Rate Associated with Malaria Endemicity?

Discoveries ◽  
2020 ◽  
Vol 8 (4) ◽  
pp. e120
Author(s):  
Abdul Rehman Arshad ◽  
◽  
Imtiaz Bashir ◽  
Farhat Ijaz ◽  
Nicholas Loh ◽  
...  

COVID-19 (coronavirus disease 2019) is a disease caused by the coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). COVID-19 has yielded many reported complications and unusual observations. In this article, we have reviewed one such observation: an association between malaria endemicity and reduced reported COVID-19 fatality. Malaria-endemic regions have a significantly lower reported COVID-19 fatality rate as compared to regions where malaria is non-endemic. Statistical analyses show that there is a strong negative correlation between the reported SARS-CoV-2 fatality and endemicity of malaria. In this review, we have discussed the potential role of CD-147, and potential malaria-induced immunity and polymorphisms in COVID-19 patients. Noteworthy, the results may also be due to underreported cases or due to the economic, political, and environmental differences between the malaria endemic and non-endemic countries. The study of this potential relationship might be of great help in COVID-19 therapy and prevention.

2021 ◽  
Vol 5 (1) ◽  
Author(s):  
Moon Ley Tung ◽  
Bryce Tan ◽  
Robin Cherian ◽  
Bharatendu Chandra

Abstract As the coronavirus disease 2019 (COVID-19) pandemic, which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is spreading rapidly worldwide, it has emerged as a leading cause of mortality, resulting in >1 million deaths over the past 10 months. The pathophysiology of COVID-19 remains unclear, posing a great challenge to the medical management of patients. Recent studies have reported an unusually high prevalence of thromboembolic events in COVID-19 patients, although the mechanism remains elusive. Several studies have reported the presence of aPLs in COVID-19 patients. We have noticed similarities between COVID-19 and APS, which is an autoimmune prothrombotic disease that is often associated with an infective aetiology. Molecular mimicry and endothelial dysfunction could plausibly explain the mechanism of thrombogenesis in acquired APS. In this review, we discuss the clinicopathological similarities between COVID-19 and APS, and the potential role of therapeutic targets based on the anti-phospholipid model for COVID-19 disease.


2020 ◽  
Vol 9 (8) ◽  
pp. 2586 ◽  
Author(s):  
Eilidh Bruce ◽  
Fenella Barlow-Pay ◽  
Roxanna Short ◽  
Arturo Vilches-Moraga ◽  
Angeline Price ◽  
...  

Coronavirus disease 2019 (COVID-19) infection causes acute lung injury, resulting from aggressive inflammation initiated by viral replication. There has been much speculation about the potential role of non-steroidal inflammatory drugs (NSAIDs), which increase the expression of angiotensin-converting enzyme 2 (ACE2), a binding target for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to enter the host cell, which could lead to poorer outcomes in COVID-19 disease. The aim of this study was to examine the association between routine use of NSAIDs and outcomes in hospitalised patients with COVID-19. This was a multicentre, observational study, with data collected from adult patients with COVID-19 admitted to eight UK hospitals. Of 1222 patients eligible to be included, 54 (4.4%) were routinely prescribed NSAIDs prior to admission. Univariate results suggested a modest protective effect from the use of NSAIDs, but in the multivariable analysis, there was no association between prior NSAID use and time to mortality (adjusted HR (aHR) = 0.89, 95% CI 0.52–1.53, p = 0.67) or length of stay (aHR 0.89, 95% CI 0.59–1.35, p = 0.58). This study found no evidence that routine NSAID use was associated with higher COVID-19 mortality in hospitalised patients; therefore, patients should be advised to continue taking these medications until further evidence emerges. Our findings suggest that NSAID use might confer a modest benefit with regard to survival. However, as this finding was underpowered, further research is required.


Author(s):  
Antoni Soriano-Arandes ◽  
Berta Ferran ◽  
Magda Campins ◽  
Juliana Esperalba-Esquerra ◽  
Juliana Reyes-Urueña ◽  
...  

We analyzed the characteristics of the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infected children during lock-down period in Catalonia (Spain), and their transmission role within the households. Among 295 traced household contacts of 89 pediatric patients, children were classified as final index cases in only 3.4% of the traced homes.


Author(s):  
Amin Daei Sorkhabi ◽  
Aila Sarkesh ◽  
Alireza Daei Sorkhabi ◽  
Taher Entezari-Maleki ◽  
Jalil Rashedi ◽  
...  

Abstract The recent pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus Disease 2019 (COVID-19) has introduced itself into the human population in the 21st century after the coronavirus diseases SARS-CoV and Middle East respiratory syndrome (MERS-CoV). Major investigations are underway worldwide in the search for pharmaceutical interventions for COVID-19 and many agents are administered in off-label routes. Several cases are under study to check or restrict clinical manifestations of COVID-19. According to the fact that the efficacy of some micro-nutrients like vitamins is proven to treat or prevent infectious diseases because of their antimicrobial and immunomodulatory activity, the potential role of vitamins in the COVID-19 treatment or prevention must be considered.


2020 ◽  
Author(s):  
Paolo Di Girolamo

Abstract The Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2), which exploded in Wuhan (Hebei Region, China) in late 2019, has recently spread around the World, causing pandemic effects on humans. Italy, and especially its Northern regions around the Po Valley, has been facing severe effects in terms of infected individuals and casualties (more than 31.000 deaths and 255.000 infected people by mid-May 2020). While the spread and effective impact of the virus is primarily related to the life styles and social habits of the different human communities, environmental and meteorological factors also play a role. Among these, pollution from PM2.5/PM10 particles, which may directly impact on the human respiratory system or act as virus carrier, thus behaving as potential amplifying factors in the pandemic spread of SARS-CoV-2. Enhanced levels of PM2.5/PM10 particles in Northern Italy were observed over the two month period preceding the virus pandemic spread. Threshold levels for PM10 (<50 µg/m³) were exceeded on 20-35 days over the period January-February 2020 in many areas in the Po Valley, where major effects in terms of infections and casualties occurred, with levels in excess of 80 µg/m³ occasionally observed in the 1-3 weeks preceding the contagious activation around February 25th. Threshold values for PM2.5 indicted in WHO air quality guidelines (<25 µg/m³) were exceeded on more than 40 days over the period January-February 2020 in large portions of the Po Valley, with levels up to 70 µg/m³ observed in the weeks preceding the contagious activation. The evolution of particle matter concentration levels throughout the month of February 2020 was carefully monitored and results are reported in the paper.In this paper PM10 particle measurements are compared with epidemiologic parameters data. Specifically, a statistical analysis is carried out to correlate the infection rate, or incidence of the pathology, the mortality rate and the case fatality rate with PM concentration levels. The study considers epidemiologic data for all 110 Italian Provinces, as reported by the Italian Statistics Institute (ISTAT, 2020), over the period 20 February-31 March 2020. Corresponding PM10 concentration levels were collected from the network of air quality monitoring stations run by different Regional and Provincial Environment Agencies, covering the period 15-26 February 2020. The case fatality rate is found to be highly correlated to the average PM10 concentration, with a correlation coefficient of 0.89 and a slope of the regression line of (6.7±0.3)×10-3 m³/µg, which implies a doubling (from 3 to 6 %) of the mortality rate of infected patients for an average PM10 concentration increase from 22 to 27 μg/m³. Infection and mortality rates are also found to be correlated with PM10 concentration levels, with correlation coefficients being 0.82 and 0.80, respectively, and the slopes of the regression lines indicating a doubling (from 1 to 2 ‰) of the infection rate and a tripling (from 0.1 to 0.3 ‰) of the mortality rate for an average PM10 concentration increase from 25 to 29 μg/m³. Epidemiologic parameters data were also compared with population density data, but no clear evidence of a mutual correlation between these quantities was found. Considerations on the exhaled particles' sizes and concentrations, their residence times, transported viral dose and minimum infective dose, in combination with PM2.5/PM10 pollution measurements and an analytical microphysical model, allowed assessing the potential role of airborne transmission through virus-transmitting PM particles, in addition to droplet transmission, in conveying SARS-CoV-2 in the human respiratory system.


Author(s):  
Paolo Di Girolamo

AbstractThe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which exploded in Wuhan (Hebei Region, China) in late 2019, has later spread around the world, causing pandemic effects on humans. During the first wave of the pandemic, Italy, and especially its Northern regions around the Po Valley, faced severe consequences in terms of infected individuals and casualties (more than 31,000 deaths and 255,000 infected people by mid-May 2020). While the spread and effective impact of the virus is primarily related to the lifestyles and social habits of the different human communities, environmental and meteorological factors also play a role. Among these, particulate pollution may directly impact the human respiratory system or act as virus carrier, thus behaving as potential amplifying factor in the pandemic spread of SARS-CoV-2. Enhanced levels of PM2.5 and PM10 particles in Northern Italy were observed over the 2-month period preceding the virus pandemic spread. Threshold levels for PM10 (< 50 μg/m3) were exceeded on 20–35 days over the period January–February 2020 in many areas in the Po Valley, where major effects in terms of infections and casualties occurred, with levels in excess of 80 μg/m3 occasionally observed in the 1–3 weeks preceding the contagious activation around February 25, 2020. Threshold values for PM2.5 indicated in WHO air quality guidelines (< 25 μg/m3) were exceeded on more than 40 days over the period January–February 2020 in large portions of the Po Valley, with levels up to 70 μg/m3 observed in the weeks preceding the contagious activation. In this paper, PM10 particle measurements are compared with epidemiologic parameters’ data. Specifically, a statistical analysis is carried out to correlate the infection rate, or incidence of the pathology, the mortality rate, and the case fatality rate with PM concentrations. The study considers epidemiologic data for all 110 Italian provinces, as reported by the Italian Statistics Institute, over the period 20 February–31 March 2020. Corresponding PM10 concentrations covering the period 15–26 February 2020 were collected from the network of air quality monitoring stations run by different regional and provincial environment agencies. The case fatality rate is found to be highly correlated to the average PM10 concentration, with a correlation coefficient of 0.89 and a slope of the regression line of (6.7 ± 0.3) × 10−3 m3/μg, which implies a doubling (from 3 to 6%) of the mortality rate of infected patients for an average PM10 concentration increase from 22 to 27 μg/m3. Infection and mortality rates are also found to be correlated with PM10 concentrations, with correlation coefficients being 0.82 and 0.80, respectively, and the slopes of the regression lines indicating a doubling (from 1 to 2‰) of the infection rate and a tripling (from 0.1 to 0.3‰) of the mortality rate for an average PM10 concentration increase from 25 to 29 μg/m3. Considerations on the exhaled particles’ sizes, their concentrations and residence times, the transported viral dose and the minimum infective dose, in combination with PM2.5 and PM10 pollution measurements and an analytical microphysical model, allowed assessing the potential role of airborne transmission through virus-laden PM particles, in addition to droplet and the traditional airborne transmission, in conveying SARS-CoV-2 in the human respiratory system. In specific circumstances which can be found in indoor environments, the number of small potentially infectious particles coalescing on PM2.5 and PM10 particles is estimated to exceed the number of infectious particles needed to activate COVID-19 infection in humans.


2021 ◽  
Vol 17 (14) ◽  
Author(s):  
Bianka Hoxha ◽  
Arvjola Hodaj

Aim: The aim of the research is to evidence the potential role of lactoferrin (LF) and heparin in coronavirus disease 2019 (COVID-19). Moreover, we discuss and underline the mechanisms involved in this possible association. Methods: PubMed and Scopus databases were used to conduct the literature search. Findings and Conclusion: Studies have widely proven the principal activity of LF, in the inflammatory process, as an anti-inflammatory and immunomodulatory glycoprotein. Evidence shows that LF has important antibacterial and antiviral effects against human and animal pathogens. Heparin and LF could reduce viral entry by preventing the attachment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a result of competitive binding to heparan sulfate proteoglycans (HSPGs). Clinical studies are necessary to specify LF and heparin mechanisms of action and the therapeutical dose in patient affected with COVID-19.


Author(s):  
Beatrice Ragnoli ◽  
Mario Malerba

COVID-19, a novel severe acute respiratory syndrome (SARS) emerging in China’s Hubei province in late 2019, due to a new coronavirus (SARS-CoV-2), is causing a global pandemic involving many areas of the world, which so far counts more than 43 million cases and more than 1,155,000 deaths worldwide [...]


Sign in / Sign up

Export Citation Format

Share Document